Nicotine Replacement and Counseling In Adolescents
Information source: University of California, San Francisco
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Smoking Cessation
Intervention: Nicotine nasal spray (Drug); Smoking cessation counseling (Behavioral)
Phase: Phase 4
Sponsored by: University of California, San Francisco
Official(s) and/or principal investigator(s):
Mark Rubinstein, MD, Principal Investigator, Affiliation: University of California, San Francisco
The objective of this pilot study is to determine the feasibility and utility of using the
nicotine nasal spray (NNS) in adolescent smokers who want to quit smoking.
Official title: A Randomized Trial of the Nicotine Nasal Spray in Adolescent Smokers
Study design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Primary outcome: Self-reported smoking abstinence verified by both expired-air carbon monoxide and salivary cotinine.
Secondary outcome: Acceptability of the Nicotine Nasal Spray by Adolescents.
Minimum age: 15 Years.
Maximum age: 18 Years.
- Be between 15 and 18 years-old
- Smoke 5 or more cigarettes per day (cpd) for at least 6 months and want to quit
- Adolescents who were using or had used nicotine replacement in the prior week were
- Those who used bupropion (Zyban®) within the past 30 days were also excluded.
Locations and Contacts
UCSF, San Francisco, California 94118, United States
Starting date: September 2005
Ending date: July 2007
Last updated: February 27, 2008